Adoptive transfer of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T cells with in vitro antitumor activity boosts LMP2-specific immune response in a patient with EBV-related nasopharyngeal carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/14679129

Download in:

View as

General Info

PMID
14679129